[HTML] sciencedirect.com

[HTML][HTML] Remdesivir, Molnupiravir and Nirmatrelvir remain active against SARS-CoV-2 Omicron and other variants of concern

L Vangeel, W Chiu, S De Jonghe, P Maes, B Slechten… - Antiviral research, 2022 - Elsevier
We assessed the in vitro antiviral activity of remdesivir and its parent nucleoside GS-441524,
molnupiravir and its parent nucleoside EIDD-1931 and the viral protease inhibitor …
被引用次数：412 相关文章

Remdesivir, Molnupiravir and Nirmatrelvir remain active against SARS-CoV-2 Omicron and other variants of concern

L Vangeel, W Chiu, S De Jonghe, P Maes… - Antiviral …, 2022 - pubmed.ncbi.nlm.nih.gov
We assessed the in vitro antiviral activity of remdesivir and its parent nucleoside GS-441524,
molnupiravir and its parent nucleoside EIDD-1931 and the viral protease inhibitor …

Remdesivir, Molnupiravir and Nirmatrelvir remain active against SARS-CoV-2 Omicron and other variants of concern.

L Vangeel, W Chiu, S De Jonghe, P Maes, B Slechten… - 2021 - pesquisa.bvsalud.org
Remdesivir, Molnupiravir and Nirmatrelvir remain active against SARS-CoV-2 Omicron and
other variants of concern. | PREPRINT-BIORXIV loading 1 2 3 +A A -A 3.Remdesivir …

Remdesivir, Molnupiravir and Nirmatrelvir remain active against SARS-CoV-2 Omicron and other variants of concern

L Vangeel, W Chiu, S De Jonghe, P Maes, B Slechten… - 2021 - lirias.kuleuven.be
We assessed the in vitro antiviral activity of remdesivir and its parent nucleoside GS-441524,
molnupiravir and its parent nucleoside EIDD-1931 and the viral protease inhibitor …
[PDF] academia.edu

[PDF][PDF] Remdesivir, Molnupiravir and Nirmatrelvir remain active against SARS-CoV-2 Omicron and other variants of concern.

L Vangeel, W Chiu, S De Jonghe, P Maes, B Slechten… - academia.edu
We assessed the in vitro antiviral activity of remdesivir and its parent nucleoside GS-441524,
molnupiravir and its parent nucleoside EIDD-1931 and the viral protease inhibitor …

[引用][C] Remdesivir, Molnupiravir and Nirmatrelvir remain active against SARS-CoV-2 Omicron and other variants of concern

L Vangeel, W Chiu, S De Jonghe, P Maes… - Antiviral Research, 2022 - cir.nii.ac.jp
Remdesivir, Molnupiravir and Nirmatrelvir remain active against SARS-CoV-2 Omicron and
other variants of concern | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ …
[HTML] europepmc.org

[HTML][HTML] Remdesivir, Molnupiravir and Nirmatrelvir remain active against SARS-CoV-2 Omicron and other variants of concern

L Vangeel, W Chiu, S De Jonghe, P Maes, B Slechten… - 2021 - europepmc.org
We assessed the in vitro antiviral activity of remdesivir and its parent nucleoside GS-441524,
molnupiravir and its parent nucleoside EIDD-1931 and the viral protease inhibitor …

Remdesivir, Molnupiravir and Nirmatrelvir remain active against SARS-CoV-2 Omicron and other variants of concern

L Vangeel, S De Jonghe, P Maes, B Slechten… - bioRxiv, 2021 - biorxiv.org
The in vitro effect of GS-441524, remdesivir, EIDD-1931, molnupiravir and nirmatrelvir
against the various SARS-CoV-2 VOCs, including Omicron, was determined. VeroE6-GFP …
[HTML] nih.gov

[HTML][HTML] Remdesivir, Molnupiravir and Nirmatrelvir remain active against SARS-CoV-2 Omicron and other variants of concern

L Vangeel, W Chiu, S De Jonghe, P Maes… - Antiviral …, 2022 - ncbi.nlm.nih.gov
We assessed the in vitro antiviral activity of remdesivir and its parent nucleoside GS-441524,
molnupiravir and its parent nucleoside EIDD-1931 and the viral protease inhibitor …
[PDF] archive.org

[PDF][PDF] Remdesivir, Molnupiravir and Nirmatrelvir remain active against SARS-CoV-2 Omicron and other variants of concern.

L Vangeel, W Chiu, S De Jonghe, P Maes, B Slechten… - scholar.archive.org
We assessed the in vitro antiviral activity of remdesivir and its parent nucleoside GS-441524,
molnupiravir and its parent nucleoside EIDD-1931 and the viral protease inhibitor …